Local Affiliate Services

Strengthen your presence in Europe with our customizable solutions that are designed to meet your specific business size and needs. Offering complete support throughout the product’s life cycle.

 

 

Comprehensive, Localized Services Across Europe

With complex regional regulatory environments, pharmaceutical, biotechs, and medical device companies face managing multiple safety and compliance needs. We support local affiliates to ensure there is always consistency, regardless of location. Our experts streamline processes and provide local knowledge — taking you through the development, approval, launch, and license maintenance of medicinal products.

 

Global Reach with Local Expertise

We recognize that a genuine understanding of local regulations and requirements, whilst respecting cultural nuances and languages, alongside meeting your goals, is vital.

End-to-End Support

Our Local Affiliate services can take you from pre-submission to post-approval and manage the maintenance of your mature portfolio – supporting you across the entire product lifecycle. 

Customized to Fit Your Needs

Our solutions and strategies can be tailored to fit your needs, with the ability to scale up when needed. Our experts can act as an extension to your departments, or you can outsource all responsibilities.   

ProPharma's Local Affiliate Services

Expand your capabilities with confidence. With experts located across Europe, our local affiliate services
provide support throughout the entire product lifecycle, ensuring that you meet local requirements and regulations.

Regulatory Sciences

We’re proud to say we are the World’s Leading Regulatory Consultancy, with decades of experience across all drug types (small molecule, biologics, oligonucleotides, and combination products) and medical device classes.

We offer flexible solutions tailored to meet your needs, with options ranging from project-based services, where our consultants work as an integrated part of your team, spanning to a fully outsourced mode, where we will take care of all of your regulatory activities

 

navigating-regulatory-submissions-webinar-thumbnail
1-4

Quality & Compliance

Our full suite of Quality and Compliance (Q&C) services helps clients across the EEA with customized solutions to fit their specific needs. Our team of highly skilled Qualified Persons (QPs), Responsible Persons (RPs), and Quality Assurance (QA) officers have helped many clients obtain and maintain their WDA/MIA licenses. We also hold our own MIA license in both the UK and EU, if you would like to outsource your batch certification entirely, and offer global auditing services with over 350 vetted auditors worldwide.

 

Pharmacovigilance

Our full suite of customizable Pharmacovigilance (PV) services can provide you with expertise in set-up and maintenance of global and local PV systems, including Qualified Person responsible for Pharmacovigilance (QPPV) & local QPPV (LPPV) services, ICSR management, aggregate report writing, Pharmacovigilance System Master File (PSMF) and Risk Management Plan (RMP) development and maintenance, literature screenings, signal management and regulatory intelligence. Our team of qualified experts, combined with integrated technology, ensure your product meets the highest levels of compliance with both regional and global regulations.

 

2-Aug-15-2024-05-01-55-8417-PM
3-Aug-15-2024-05-02-08-4076-PM

Contact Center Support

With our scalable and 24/7 availability contact centers, we offer multilingual support from native-speaking medical professionals, so we can respond to product inquiries in a swift manner that is consistent with product labeling and regulatory guidance, but also with local evidence, culture, and communication styles.

In Europe, our experts offer support in English, French, German, Italian, Spanish, Dutch, Czech, Danish, Finnish, Greek, Hungarian, Norwegian, Polish, Portuguese, Romanian, Russian, Slovakian, Swedish, Arabic, and Turkish.

We also offer solutions to support patients, caregivers, and healthcare professionals to initiate and sustain therapies, helping them to overcome barriers and achieve better health outcomes.

 

ProPharma's diverse team of experts has extensive expertise spanning across
regulatory, market access, GMP/GDP, pharmacovigilance and medical information.

Local Regulatory Support

With a team of experts boasting deep-rooted knowledge in regulatory affairs, including former EU Regulatory Agency and ex-CHMP staff, alongside seasoned industry professionals with decades of experience, we offer the comprehensive support and strategic direction needed to move your product from one regulatory hurdle to the next. 

Market Authorization & Local Product Launch

  • Europe: Centralized, MRP, DCP and National US: NDA, BLA and ANDA
  • GAP analysis and submission strategy
  • Dossier compilation/medical writing
  • Pre-submission meetings
  • MAH-transfer projects
  • Publishing (eCTD/CESP) 
  • Product launch checklist 
  • Review of artwork for printing
  • Registration in local regulatory databases
  • Local country regulatory advice

Product Lifecycle Management

  • Regulatory advice
  • Health authority liaison services (communication)
  • Publishing (eCTD)
  • Regulatory submissions (e.g., variation applications, line extensions, and renewals)
  • Support for post-authorization commitments
  • Product information (PI) updates/translations 
  • Artwork reviews
  • Management of catalogue texts and local regulatory databases 

Regulatory Review of Promotional Materials

  • Regulatory review of promotional and non-promotional materials and activities in accordance with the respective ethical codes in the local country
  • Creation and update of Abbreviated Product Information (API) texts
  • Support in setting up a routine for local review of promotional materials in the local country
  • Advice on general questions regarding the local ethical codes 

Market Access - Pricing & Reimbursement

  • Payer landscape reviews and market assessment 
  • Stakeholder mapping 
  • Payer and KOL engagement
  • Product Positioning
  • Payer-relevant evidence –global value dossiers including cost-effectiveness and budget impact modelling.
  • Participation in advisory boards and expert focus groups
  • Policy and publication support – expert guidance for the local region

Quality and Compliance

Our Q&C team consists of over 100 highly experienced consultants that are based across the EU and UK, creating a large network of knowledge on both EU and local requirements. Our cumulative experience covers multiple types of formulations, complex supply chains, scale-up activities, technical transfer projects, aseptic/sterile manufacturing, radiopharmaceuticals, biologics, ATMPs, medical device, supply for clinical trials, and Wholesaler Dealer Authorization (WDA) application and maintenance. 

MIA License Support

  • Outsource your QP release through the ProPharma Group MIA
  • Support with obtaining an Importation Licence for Switzerland
  • Handling your product complaints.
  • Auditing covering all GxP areas and CSV, providing you with a complete solution for your audit schedule
  • Training

Global GxP Auditing

  • We can take care of your complete audit schedule.
  • GMP, GDP and GVP electronic Quality Management Systems (eQMS), gap analysis, SOP development, optimisation and management  
  • Regulatory inspections, mock audits, training, and remediation 
  • Authorithies inspection support
  • Applying for API import and Brokers Licences

Product Lifecycle Management

  • CLO, CDMO and 3PL licensing, selection and management
  • Technical transfer
  • Nitrosamine assessments
  • Manufacturing scale up
  • Analytical method validation and transfer
  • Shipment validation
  • Product and process development
  • Supply chain establishment and management

Advanced Therapy Medicinal Product Support

  • Gaining authorisation for GMOs handling
  • Product and process development and scale up
  • Analytical method development, validation, and transfer
  • CLO, CDMO and 3PL licensing, selection and management
  • Facility setup, qualification and authorities inspection support

Pharmacovigilance

Our pharmacovigilance (PV) experts understand the regulations in place at the European level as well as those at a country level too. We offer a range of services that can be tailored to your needs, this includes setting up of a new PV system, product launch support, benefit risk evaluation to ensure patients' safety, risk minimization activities and, PV consultancy during any types of authorization procedures.

Qualified Person Responsible for Pharmacovigilance (QPPV)

Every marketing authorization holder (MAH) in Europe has to establish a PV system for the fulfilment of PV tasks for its products. When setting up a PV system in Europe, the MAH must appoint an EU/UK QPPV to establish and maintain the MAH’s PV system. We can provide you with qualified and experienced QPPVs.

Pharmacovigilance System Master File (PSMF)

A PV system monitors the safety of authorized medicinal products. The EU PSMF is a legally required document that provides a comprehensive description of the MAH’s PV system. Our QPPV office team has extensive experience working with many different PV systems and annually are responsible for the creation and maintenance of 50 client PSMFs.

Role of Local Person for Pharmacovigilance (LPPV)

Many European countries legally require a LPPV at a country level who report to the EU QPPV. Although the requirements and responsibilities of an EU QPPV are specified in EU legislation, LPPVs are subject to their own national legislation. We can provide you with a LPPV to ensure your compliance with the regulations in place.

Standard Operating Procedures and Work Instructions

Our experts can write your quality system documents, like standard operating procedures (SOPs) and work instructions (WIs), ensuring you meet European regulations and requirements and remain compliant.

Contact Center Support

In addition to our scalable, 24/7 available contact centers, we offer adverse event (AE) intake and follow-up services, product complaint intake and follow-up services, patient and commercial services, and medical writing. Our experts offer support in English, French, German, Italian, Spanish, Dutch, Czech, Danish, Finnish, Greek, Hungarian, Norwegian, Polish, Portuguese, Romanian, Russian, Slovakian, Swedish, Arabic, and Turkish.

Adverse Event Intake

Our skilled specialists follow processes and guidelines to obtain timely, accurate, and comprehensive AE information. Our AE collection forms can be customized for your needs in our fully validated database and our specialists are experienced with various client databases and AE forms.

Product Complaint Intake

Our MI team is trained on Product Quality Complaint (PQC) intake. We ensure that every PQC is collected for patients’ safety, customer journey, and compliance at every contact center exchange and sent to the designated quality department.

Patient Support

We offer extensive patient support and commercial services to support our clients' customers and patients. Our diverse team of global contact centers and certified field partners support patients and healthcare professionals in obtaining, understanding, and adhering to therapies for a well-rounded customer journey.

Medical Writing

Our team of writers, editors, and quality reviewers knows what it takes to produce clear, concise text for your clinical, scientific, and regulatory needs. This includes document creation, content management, response document maintenance, translation, and more.

Ready to speak with a local affiliate Expert?

With expertise across all drug types, formulations, and device risk classes, our comprehensive support covers the entire product lifecycle, from initial development until launch and product maintenance on the market.

News & Insights

How a Strong Regulatory Strategy Supports Your Product’s Success

August 14, 2024

How a Strong Regulatory Strategy Supports Your Product’s Success

A strong regulatory strategy is vital for product success, ensuring compliance, expediting approvals, and reducing costly delays in product development.

Risks to Consider when Implementing AI Technology in Medical Information

August 12, 2024

Risks to Consider when Implementing AI Technology in Medical Information

Explore the risks and benefits of implementing AI in Medical Information, from patient privacy concerns to regulatory gaps. Learn how to navigate these challenges effectively.

FDA Drug Labeling Requirements & Regulations: What’s in Your Label?

August 6, 2024

FDA Drug Labeling Requirements & Regulations: What’s in Your Label?

Explore the role of drug labeling in regulatory affairs. Learn how strategic labels can drive promotional claims, support reimbursement, & more.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

May 2, 2024

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

ProPharma and PBL introduce Cell Factory Box for decentralized Cell & Gene Therapies manufacturing, reducing costs and improving patient access to life-saving treatments.

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

April 18, 2024

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

ProPharma receives Medidata Rave EDC accreditation, enhancing clinical trial efficiency. Learn about the latest milestone delivering cutting-edge solutions.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

October 11, 2023

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

Everest Group has recognized ProPharma Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023.

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

May 2, 2024

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

ProPharma and PBL introduce Cell Factory Box for decentralized Cell & Gene Therapies manufacturing, reducing costs and improving patient access to life-saving treatments.

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

April 18, 2024

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

ProPharma receives Medidata Rave EDC accreditation, enhancing clinical trial efficiency. Learn about the latest milestone delivering cutting-edge solutions.

Previous Post Arrow Next Post Arrow
ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

October 11, 2023

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

Everest Group has recognized ProPharma Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023.

Previous Award Arrow Next Award Arrow
How a Strong Regulatory Strategy Supports Your Product’s Success

August 14, 2024

How a Strong Regulatory Strategy Supports Your Product’s Success

A strong regulatory strategy is vital for product success, ensuring compliance, expediting approvals, and reducing costly delays in product development.

Risks to Consider when Implementing AI Technology in Medical Information

August 12, 2024

Risks to Consider when Implementing AI Technology in Medical Information

Explore the risks and benefits of implementing AI in Medical Information, from patient privacy concerns to regulatory gaps. Learn how to navigate these challenges effectively.

FDA Drug Labeling Requirements & Regulations: What’s in Your Label?

August 6, 2024

FDA Drug Labeling Requirements & Regulations: What’s in Your Label?

Explore the role of drug labeling in regulatory affairs. Learn how strategic labels can drive promotional claims, support reimbursement, & more.

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow